Aurora Cannabis Inc (ACB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($17.00 Million) by net assets ($567.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Aurora Cannabis Inc to measure how many days the company can operate on defensive assets alone.

Aurora Cannabis Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aurora Cannabis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aurora Cannabis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Cannabis Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Enad Global 7 AB
ST:EG7
0.015x
Insight Digital Partners II Class A Ordinary Shares
NASDAQ:DYOR
-0.002x
Goodway Machine Corp
TW:1583
0.015x
United Pharm
KO:033270
0.077x
Strickland Metals Ltd
AU:STK
-0.004x
Aurora Cannabis Inc
TO:ACB
0.030x
Mega Uranium Ltd.
TO:MGA
-0.007x
Sparebank 1 Nordvest
OL:SNOR
-0.029x

Annual Cash Flow Conversion Efficiency for Aurora Cannabis Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Cannabis Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Aurora Cannabis Inc market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $605.09 Million $16.00 Million 0.026x +123.28%
2024-03-31 $602.92 Million $-68.51 Million -0.114x +48.81%
2023-03-31 $521.74 Million $-115.82 Million -0.222x -5.04%
2022-03-31 $521.74 Million $-110.27 Million -0.211x -104.26%
2021-03-31 $2.04 Billion $-210.58 Million -0.103x +36.06%
2020-03-31 $2.11 Billion $-342.14 Million -0.162x -270.73%
2019-03-31 $4.40 Billion $-192.25 Million -0.044x +16.43%
2018-03-31 $1.56 Billion $-81.67 Million -0.052x +14.22%
2017-03-31 $219.71 Million $-13.38 Million -0.061x +94.84%
2016-03-31 $5.74 Million $-6.77 Million -1.180x -36.07%
2015-03-31 $3.83 Million $-3.32 Million -0.867x -22.12%
2014-03-31 $1.36 Million $-965.11K -0.710x -9.48%
2013-03-31 $690.35K $-447.84K -0.649x -152.05%
2012-03-31 $1.08 Million $-277.98K -0.257x -28.38%
2011-03-31 $1.37 Million $-275.48K -0.200x -11027.01%
2010-03-31 $1.71 Million $-3.08K -0.002x +92.54%
2009-03-31 $1.62 Million $-39.04K -0.024x +53.41%
2008-03-31 $1.68 Million $-87.26K -0.052x -677.32%
2007-03-31 $1.68 Million $15.11K 0.009x --

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$173.24 Million
Market Cap Rank
#17189 Global
#4011 in USA
Share Price
$2.93
Change (1 day)
+0.34%
52-Week Range
$2.92 - $6.23
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more